Skip to main content

[vc_row][vc_column][vc_single_image image="69519" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] A group of researchers, whose work has been supported by the National Foundation for Cancer Research (NFCR), has created a powerful piece of software that allows scientists to model tumor growth, immune responses, and treatment outcomes in a virtual environment.   The...

[vc_row][vc_column][vc_single_image image="67187" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Researchers have found a promising biomarker that may help doctors predict which patients with extensive-stage small cell lung cancer (ES-SCLC) are most likely to respond to tarlatamab. This targeted immunotherapy is possible because of new insights into DLL3 biology, partially...

[vc_row][vc_column][vc_single_image image="64144" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]A new article by NFCR-supported scientist Dr. Valerie Weaver, titled "Tissue Mechanics in Tumor Heterogeneity and Aggression" (PMID: 40307158), was published in the April 2025 issue of Trends in Cancer. The article provides a comprehensive review of how the tumor...

[vc_row][vc_column][vc_single_image image="48283" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]The prevalence of skin cancer is rising at an alarming rate, with melanoma being the deadliest. Melanoma is renowned for quickly spreading to other organs (or metastasizing), drastically decreasing the likelihood of survival. Being able to stop the spread of...